SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001213900-20-023389
Filing Date
2020-08-24
Accepted
2020-08-24 10:44:06
Documents
3
Group Members
DANIEL HOPPDH-CAPITAL GMBH & CO. KGDH-LT-INVESTMENTS GMBHDIETMAR HOPPDR. MATHIAS HOTHUMOH BETEILIGUNGEN GMBH & CO. KGOLIVER HOPPPROF. DR. CHRISTOF HETTICHPROF. DR. FRIEDRICH VON BOHLEN UND HALBACH

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ea125893-13ddievini_curevac.htm SC 13D 257984
2 POWER OF ATTORNEY ea125893ex99-1dievini_curev.htm EX-99.1 18041
3 JOINT FILING AGREEMENT ea125893ex99-2dievini_curev.htm EX-99.2 15025
  Complete submission text file 0001213900-20-023389.txt   292973
Mailing Address JOHANN-JAKOB-ASTOR STR. 57 WALLDORF 2M 69190
Business Address JOHANN-JAKOB-ASTOR STR. 57 WALLDORF 2M 69190 62278608462
dievini Hopp BioTech holding GmbH & Co KG (Filed by) CIK: 0001696029 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: SC 13D

Mailing Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076
Business Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076 49 7071 9883 0
CureVac N.V. (Subject) CIK: 0001809122 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91630 | Film No.: 201125341
SIC: 2834 Pharmaceutical Preparations